CRP and COVID-19: Taking into account that a timely administration of EGCG to COVID-19 patients is most likely crucial, we suggest administering EGCG, orally, at the dosage of 600–900 mg/die, once the symptoms aggravate and/or the blood C-reactive protein, or other markers of inflammation, increase.